Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Bick

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
The Medical Clinics of North America|May 1, 1994
Current trends in the development of anticoagulant and antithrombotic drugsJ Fareed, D Hoppensteadt, J M Walenga, et al.
Medscape Women'S Health|September 10, 1998
Recurrent miscarriage: causes, evaluation, and treatmentR L Bick, J Madden, K B Heller, et al.
Thrombosis Research|August 1, 1976
Daunomycin and fibrinolysisR L Bick, G Murano, L Fekete, et al.
Thrombosis Research|May 1, 1977
Antithrombin III(AT-III) as a diagnostic aid in disseminated intravascular coagulationR L Bick, M L Dukes, W L Wilson, et al.
Clinics in Laboratory Medicine|March 1, 1995
Laboratory diagnosis of antiphospholipid syndromesH Reyes, L Dearing, R L Bick, et al.
Vascular Surgery|September 1, 1975
Hemostatic defects induced by cardiopulmonary bypassR L Bick, N Arbegast, L Crawford, et al.
Clinical Chemistry|September 1, 1983
Molecular markers of hemostatic disorders: implications in the diagnosis and therapeutic management of thrombotic and bleeding disordersJ Fareed, R L Bick, G Squillaci, et al.
International Angiology : a Journal of the International Union of Angiology|December 17, 2008
Contaminants in heparins continue to be unfoldedJ Fareed, M Ahluwalia, R Wahi, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Acquired defects of fibrinolysis associated with thrombosisJ Fareed, D A Hoppensteadt, W P Jeske, et al.
International Journal of Hematology|October 1, 1996
Hodgkin's disease in association with hexavalent chromium exposureR L Bick, T V Girardi, W J Lack, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
The Medical Clinics of North America|May 1, 1994
Current trends in the development of anticoagulant and antithrombotic drugsJ Fareed, D Hoppensteadt, J M Walenga, et al.
Medscape Women'S Health|September 10, 1998
Recurrent miscarriage: causes, evaluation, and treatmentR L Bick, J Madden, K B Heller, et al.
Thrombosis Research|August 1, 1976
Daunomycin and fibrinolysisR L Bick, G Murano, L Fekete, et al.
Thrombosis Research|May 1, 1977
Antithrombin III(AT-III) as a diagnostic aid in disseminated intravascular coagulationR L Bick, M L Dukes, W L Wilson, et al.
Clinics in Laboratory Medicine|March 1, 1995
Laboratory diagnosis of antiphospholipid syndromesH Reyes, L Dearing, R L Bick, et al.
Vascular Surgery|September 1, 1975
Hemostatic defects induced by cardiopulmonary bypassR L Bick, N Arbegast, L Crawford, et al.
Clinical Chemistry|September 1, 1983
Molecular markers of hemostatic disorders: implications in the diagnosis and therapeutic management of thrombotic and bleeding disordersJ Fareed, R L Bick, G Squillaci, et al.
International Angiology : a Journal of the International Union of Angiology|December 17, 2008
Contaminants in heparins continue to be unfoldedJ Fareed, M Ahluwalia, R Wahi, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Acquired defects of fibrinolysis associated with thrombosisJ Fareed, D A Hoppensteadt, W P Jeske, et al.
International Journal of Hematology|October 1, 1996
Hodgkin's disease in association with hexavalent chromium exposureR L Bick, T V Girardi, W J Lack, et al.
Pageof 12